Analystreport

Celldex Therapeutics, Inc. (NASDAQ: CLDX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Celldex Therapeutics, Inc.  (CLDX) 
Last celldex therapeutics, inc. earnings: 11/12 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com